Cytosorbents Gross Profit from 2010 to 2025

CTSO Stock

USD 0.98 0.11 10.09%

Cytosorbents Crp Gross Profit yearly trend continues to be very stable with very little volatility. Gross Profit is likely to grow to about 27 M this year. Gross Profit is the profit Cytosorbents Crp makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2005-09-30

Previous Quarter

6.5 M

Current Value

4.5 M

Quarterly Volatility

2.7 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents Crp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 135 K or Selling General Administrative of 45.7 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.002 or PTB Ratio of 2.01. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.

Check out the analysis of Cytosorbents Crp Correlation against competitors.

To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Latest Cytosorbents Crp's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Cytosorbents Crp over the last few years. Gross profit is a required income statement account that reflects total revenue of Cytosorbents Crp minus its cost of goods sold. It is profit before Cytosorbents Crp operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Cytosorbents Crp's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 23.67 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Cytosorbents Gross Profit Regression Statistics

	Arithmetic Mean	11,873,272
	Geometric Mean	3,358,831
	Coefficient Of Variation	97.59
	Mean Deviation	10,153,128
	Median	12,762,983
	Standard Deviation	11,587,468
	Sample Variance	134.3T
	Range	30.2M
	R-Value	0.91
	Mean Square Error	25.1T
	R-Squared	0.83
	Slope	2,211,381
	Total Sum of Squares	2014T

Cytosorbents Gross Profit History

	2025	27 M
	2024	25.8 M
	2023	22.4 M
	2022	15.4 M
	2021	29.1 M
	2020	28.4 M
	2019	15.4 M

Other Fundumenentals of Cytosorbents Crp

Gross Profit Margin

Cytosorbents Crp Gross Profit component correlations

	Total Assets	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Total Stockholder Equity	Common Stock	Accounts Payable	Good Will	Intangible Assets	Property Plant Equipment	Long Term Debt	Net Receivables	Short Term Debt	Net Tangible Assets	Current Deferred Revenue	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.6	-0.8	0.66	0.9	0.94	-0.35	0.7	0.92	0.94	0.8	0.36	0.86	0.17	0.94	0.65	0.91	0.65	0.86	0.8	0.89	0.7	0.73
Net Debt	-0.6		0.13	0.12	-0.86	-0.8	0.16	0.04	-0.28	-0.33	-0.11	-0.15	-0.17	0.34	-0.76	-0.22	-0.35	-0.27	-0.32	-0.17	-0.85	-0.98	-0.08
Retained Earnings	-0.8	0.13		-0.84	-0.58	-0.61	0.29	-0.79	-0.91	-0.9	-0.78	-0.4	-0.91	-0.43	-0.64	-0.61	-0.9	-0.62	-0.83	-0.82	-0.49	-0.24	-0.78
Total Liab	0.66	0.12	-0.84		0.34	0.36	-0.04	0.86	0.83	0.82	0.82	0.36	0.85	0.58	0.44	0.54	0.73	0.53	0.74	0.8	0.32	0.02	0.75
Total Current Assets	0.9	-0.86	-0.58	0.34		0.96	-0.33	0.38	0.7	0.75	0.52	0.4	0.62	-0.07	0.94	0.5	0.76	0.57	0.74	0.6	0.92	0.91	0.47
Total Stockholder Equity	0.94	-0.8	-0.61	0.36	0.96		-0.42	0.47	0.76	0.79	0.62	0.28	0.67	-0.06	0.96	0.56	0.8	0.56	0.72	0.62	0.95	0.86	0.56
Common Stock	-0.35	0.16	0.29	-0.04	-0.33	-0.42		-0.3	-0.41	-0.42	-0.25	-0.44	-0.4	-0.08	-0.27	-0.23	-0.45	-0.32	-0.35	-0.38	-0.21	-0.16	-0.2
Accounts Payable	0.7	0.04	-0.79	0.86	0.38	0.47	-0.3		0.87	0.83	0.81	0.29	0.9	0.64	0.52	0.53	0.76	0.53	0.72	0.86	0.39	0.06	0.85
Good Will	0.92	-0.28	-0.91	0.83	0.7	0.76	-0.41	0.87		0.99	0.83	0.51	0.99	0.4	0.75	0.6	0.93	0.65	0.92	0.92	0.66	0.4	0.8
Intangible Assets	0.94	-0.33	-0.9	0.82	0.75	0.79	-0.42	0.83	0.99		0.84	0.53	0.97	0.34	0.78	0.63	0.94	0.66	0.93	0.91	0.7	0.46	0.77
Property Plant Equipment	0.8	-0.11	-0.78	0.82	0.52	0.62	-0.25	0.81	0.83	0.84		0.2	0.79	0.29	0.65	0.71	0.8	0.53	0.74	0.74	0.54	0.26	0.77
Long Term Debt	0.36	-0.15	-0.4	0.36	0.4	0.28	-0.44	0.29	0.51	0.53	0.2		0.5	0.19	0.16	0.08	0.38	0.32	0.56	0.53	0.17	0.19	0.02
Net Receivables	0.86	-0.17	-0.91	0.85	0.62	0.67	-0.4	0.9	0.99	0.97	0.79	0.5		0.46	0.68	0.56	0.91	0.61	0.89	0.94	0.57	0.29	0.82
Short Term Debt	0.17	0.34	-0.43	0.58	-0.07	-0.06	-0.08	0.64	0.4	0.34	0.29	0.19	0.46		-0.01	-0.01	0.28	0.59	0.25	0.54	-0.14	-0.36	0.43
Net Tangible Assets	0.94	-0.76	-0.64	0.44	0.94	0.96	-0.27	0.52	0.75	0.78	0.65	0.16	0.68	-0.01		0.61	0.83	0.58	0.76	0.64	0.94	0.84	0.68
Current Deferred Revenue	0.65	-0.22	-0.61	0.54	0.5	0.56	-0.23	0.53	0.6	0.63	0.71	0.08	0.56	-0.01	0.61		0.68	0.37	0.55	0.43	0.53	0.37	0.63
Capital Surpluse	0.91	-0.35	-0.9	0.73	0.76	0.8	-0.45	0.76	0.93	0.94	0.8	0.38	0.91	0.28	0.83	0.68		0.69	0.94	0.87	0.66	0.46	0.86
Short Long Term Debt	0.65	-0.27	-0.62	0.53	0.57	0.56	-0.32	0.53	0.65	0.66	0.53	0.32	0.61	0.59	0.58	0.37	0.69		0.63	0.7	0.43	0.3	0.58
Long Term Debt Total	0.86	-0.32	-0.83	0.74	0.74	0.72	-0.35	0.72	0.92	0.93	0.74	0.56	0.89	0.25	0.76	0.55	0.94	0.63		0.87	0.61	0.45	0.78
Long Term Investments	0.8	-0.17	-0.82	0.8	0.6	0.62	-0.38	0.86	0.92	0.91	0.74	0.53	0.94	0.54	0.64	0.43	0.87	0.7	0.87		0.5	0.27	0.78
Net Invested Capital	0.89	-0.85	-0.49	0.32	0.92	0.95	-0.21	0.39	0.66	0.7	0.54	0.17	0.57	-0.14	0.94	0.53	0.66	0.43	0.61	0.5		0.92	0.47
Net Working Capital	0.7	-0.98	-0.24	0.02	0.91	0.86	-0.16	0.06	0.4	0.46	0.26	0.19	0.29	-0.36	0.84	0.37	0.46	0.3	0.45	0.27	0.92		0.19
Capital Stock	0.73	-0.08	-0.78	0.75	0.47	0.56	-0.2	0.85	0.8	0.77	0.77	0.02	0.82	0.43	0.68	0.63	0.86	0.58	0.78	0.78	0.47	0.19

Click cells to compare fundamentals

About Cytosorbents Crp Financial Statements

Cytosorbents Crp investors utilize fundamental indicators, such as Gross Profit, to predict how Cytosorbents Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	25.8 M	27 M
Gross Profit Margin	0.55	0.58

When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:

How To Invest In Cytosorbents

Details

Is Cytosorbents Stock a good investment?

Details

What is Cytosorbents Crp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Cytosorbents Crp Correlation against competitors.

To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.36)

Revenue Per Share

0.72

Quarterly Revenue Growth

0.066

Return On Assets

(0.28)

Return On Equity

(1.19)

The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cytosorbents Gross Profit from 2010 to 2025

Latest Cytosorbents Crp's Gross Profit Growth Pattern

Cytosorbents Gross Profit Regression Statistics

Cytosorbents Gross Profit History

Other Fundumenentals of Cytosorbents Crp

Cytosorbents Crp Gross Profit component correlations

About Cytosorbents Crp Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY